# Regulatory Updates Powered by Good Face: March 2026 Edition

We're pleased to share the March 2026 edition of our Regulatory Recap, powered by Good Face.

This month’s update reflects important regulatory developments across Canada, the European Union, the United Kingdom, Australia, and international scientific bodies. Key highlights include new Ministerial Conditions under the Canadian Environmental Protection Act (CEPA), newly published SCCS final opinions in the EU, amendments to the UK Cosmetics Regulation Annexes, updates to the Australian Industrial Chemicals Inventory and Poisons Standard, and new carcinogenicity evaluations issued by IARC. Keep reading to explore these updates in detail.

### Canadian Environmental Protection Act (CEPA)

In February 2026, Canada published new Ministerial Conditions under CEPA for Siloxanes and Silicones, di-Me, Me 3-(2-oxiranylmethoxy)propyl, Me 3,3,3-trifluoropropyl (CAS 3086114-77-1). These conditions introduce specific risk management measures governing the manufacture, import, and use of this newly listed substance on the Domestic Substances List (DSL), January 28, 2026 version. Companies dealing with this substance must ensure compliance with the newly established handling and reporting requirements.

Full ministerial conditions and DSL updates can be found [here](https://gazette.gc.ca/rp-pr/p1/2026/2026-02-07/pdf/g1-16006.pdf#page=3).

### Scientific Committee on Consumer Safety (SCCS) – European Union

The SCCS published final scientific opinions on multiple cosmetic ingredients in February 2026. These opinions cover prostaglandin analogues (Methylamido-Dihydro-Noralfaprostal, Isopropyl Cloprostenate, and Dechloro Dihydroxy Difluoro Ethylcloprostenolamide), as well as Thiomersal and several phenyl mercuric salts. Final assessments were also issued for the hair dyes Basic Blue 99 and Basic Brown 16.

These scientific opinions provide updated safety assessments that may inform future amendments to the EU Cosmetics Regulation, particularly regarding concentration limits, conditions of use, or potential prohibitions.

Full SCCS opinions can be found [here – Basic Brown 16](https://health.ec.europa.eu/publications/sccs-scientific-advice-hair-dye-basic-brown-16-c009-cas-no-26381-41-9-ec-no-247-640-9-submission-v_en), [here – Basic Blue 99](https://health.ec.europa.eu/publications/sccs-scientific-advice-hair-dye-basic-blue-99-c059-cas-no-68123-13-7-ec-no-268-544-3-submissions-iv_en) and [here – Thiomersal & phenylmercuric salts](https://health.ec.europa.eu/publications/sccs-scientific-advice-safety-thiomersal-cas-no-54-64-8-ec-no-200-210-4-and-phenylmercuric-salts_en).

### UK Cosmetics Regulation

The UK adopted The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) (No. 2) Regulations 2026. Published by the Office for Product Safety and Standards (OPSS), this Statutory Instrument amends the Annexes to the UK Cosmetics Regulation, updating restrictions on certain chemical substances and introducing transitional provisions.

Full text of the Statutory Instrument is available [here](https://www.legislation.gov.uk/uksi/2026/109/contents/made).

### Australian Inventory of Industrial Chemicals (AIIC)

In February 2026, AICIS published multiple notifications updating the Australian Inventory of Industrial Chemicals. One existing listing — Decanedioic acid, reaction products with 1-octadecanamine, calcium salts (CAS 403656-24-6) — was varied following the revocation of confidential business information (CBI) approval.

Additionally, several chemicals were added to the Inventory five years after the issuance of their assessment certificates, including 1-Pyrrolidinepropanaminium derivatives (CAS 3113590-25-0) and mixed diesters of decanoic and octanoic acid (CAS 1072005-10-7).

Full notifications can be found [here – CBI revocation](https://www.industrialchemicals.gov.au/news-and-notices/variation-inventory-listing-following-revocation-cbi-approval-10-february-2026) and [here – new chemical listings](https://www.industrialchemicals.gov.au/news-and-notices/chemical-added-inventory-5-years-after-issue-assessment-certificate-25-february-2026).

### Australia – Poisons Standard (SUSMP – February 2026)

The Therapeutic (Goods Poisons Standard—February 2026) Instrument 2026 repealed the October 2025 edition and incorporates a range of updates to scheduling decisions and associated controls on medicines and chemicals as classified under the Australian Poisons Standard. This legislative instrument, effective from 30 January 2026, maintains the uniform national classification system that governs how medicines, therapeutic goods, and other substances are scheduled for safety and access control across Australia. The 2026 edition reflects numerous revisions detailed in the supporting Explanatory Statement, including updated substance classifications and scheduling rationales compared with the October 2025 version.

Full text of the February 2026 SUSMP is available [here](https://www.legislation.gov.au/F2026L00060/latest/text?utm_source=chatgpt.com).

### International Agency for Research on Cancer (IARC)

In February 2026, IARC published evaluations under Volume 137 of its Monographs programme, assessing the carcinogenic potential of Hydrochlorothiazide, Voriconazole, and Tacrolimus. These evaluations contribute to the global hazard classification framework by reviewing available scientific evidence regarding carcinogenicity in humans and experimental models.

The IARC monograph is available [here](https://monographs.iarc.who.int/news-events/volume-137-hydrochlorothiazide-voriconazole-and-tacrolimus-2/).